Latest News and Press Releases

Data show dose-dependent suppression of immune-suppressive agents GEN-1 stimulates the immune system through the production of CD4 and CD8 cells Chemotherapy Response...

Holbrook, New York, April 15, 2021 (GLOBE NEWSWIRE) -- Emerald Organic Products Inc. (d/b/a Healixa Inc.) (OTC: EMOR) (the “Company”, "EMOR", “Healixa”), a people-first digital organization that...

Alexandria, VA, Dec. 28, 2020 (GLOBE NEWSWIRE) -- AAPA commends Congress for passing legislation authorizing PAs to receive direct payment under Medicare as part of the Coronavirus Relief &...

CHICAGO, Sept. 23, 2020 (GLOBE NEWSWIRE) -- A comprehensive six-month study of patient and procedure volume at 275 hospitals by Strata Decision Technology (Strata) revealed the significant financial...

Hampton, VA, Sept. 14, 2020 (GLOBE NEWSWIRE) -- With families nationwide in search of more resources to support themselves through difficult times, the Patient Advocate Foundation relaunched the...

Treatment refractory, immunologically cold, hepatic tumor type37% reduction and 83% stabilization of treated disease (2D-EASL)Overall survival of 11 months for checkpoint inhibition-naïve patients;...

CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) -- Ongoing research from TransUnion Healthcare (NYSE: TRU) indicates overall hospital visit volumes continue to slowly recover, though hospital visit volumes...

Treatment refractory, immunologically cold, hepatic tumor type50% reduction of treated disease; 83% stabilization of overall patient disease (RECIST)Median progression-free survival not reached (by CT...

RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead...

CHICAGO, May 07, 2020 (GLOBE NEWSWIRE) -- As the world navigates the impacts of the COVID-19 pandemic, ongoing research from TransUnion Healthcare (NYSE: TRU) indicates hospital visit volumes...